MSU
MDCO

Mizuho Securities USA’s Medicines Co MDCO Stock Holding History

Mizuho Securities USA’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-23,255
Closed -$848K – 175
2019
Q2 		$848K Buy
+23,255
New +$759K 0.04% 99
2015
Q4 		– Sell
-9,000
Closed -$342K – 171
2015
Q3 		$342K Buy
+9,000
New +$316K 0.09% 87

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Mizuho Securities USA's MDCO Position: Q3 2019 in Review

Mizuho Securities USA sold out of Medicines Co (MDCO) in Q3 2019, closing a stake of 23,255 shares — an estimated $848K sold.

Mizuho Securities USA first reported a position in MDCO in Q3 2015 and held it in 2 quarters. The position peaked at $848K in Q2 2019. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

  • Mizuho Securities USA reported no remaining Medicines Co position as of Q3 2019 after selling out during the quarter.
  • Mizuho Securities USA sold 23,255 Medicines Co shares in Q3 2019, an estimated $848K.
  • Mizuho Securities USA first reported a position in Medicines Co in Q3 2015 and held it in 2 quarters.
  • Mizuho Securities USA's Medicines Co position peaked at $848K in Q2 2019.
  • 250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on Mizuho Securities USA's 13F filing for Q3 2019, filed 31 Oct 2019.